Literature DB >> 18662848

Reversal of the malignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene.

Huijuan Wu1, Shixuan Wang, Danghui Weng, Hui Xing, Xiaohong Song, Tao Zhu, Xi Xia, Yanjie Weng, Gang Xu, Li Meng, Jianfeng Zhou, Ding Ma.   

Abstract

OBJECTIVE: PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a tumor suppressor gene identified on human chromosome 10q23. Substantial studies have demonstrated that PTEN can inhibit cell proliferation, migration and invasion of many cancer cells. The purpose of this study was to determine whether upregulation of PTEN gene by transfection wild-type PTEN gene to ovarian cancer cells can inhibit growth and migration and to explore the potential for PTEN gene therapy of ovarian cancers.
METHOD: Wild-type and phosphatase-inactive (C124A) PTEN plasmids were transfected into ovarian epithelial cancer A2780 cells, and their effects on cell apoptosis, cell proliferation, cell migration and cell invasion were analyzed by flow cytometry analysis, TUNEL assay, MTT assay, wound-healing assay and transwell assay.
RESULTS: Both wild-type and mutant PTEN can upregulate the expression of PTEN gene dramatically; however, it is wild-type PTEN not phosphatase-inactive PTEN that can induce apoptosis and decrease cell migration, invasion and proliferation in ovarian cancer cells.
CONCLUSION: These results demonstrated that PTEN had played an important role in the cell proliferation, cell migration and invasion dependent on its phosphatase activity. Enhanced expression of PTEN by gene transfer is sufficient to reverse the malignant phenotype of ovarian cancer cells and transfection of ovarian cancer cells with wild-type PTEN gene might be another novel approach for therapeutic intervention in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662848     DOI: 10.1016/j.canlet.2008.06.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  miR-29b regulates migration of human breast cancer cells.

Authors:  Chen Wang; Zhen Bian; Da Wei; Jian-guo Zhang
Journal:  Mol Cell Biochem       Date:  2011-02-26       Impact factor: 3.396

2.  PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells.

Authors:  Wallace Martins de Araújo; Flavia Castello Branco Vidal; Waldemir Fernandes de Souza; Julio César Madureira de Freitas; Wanderley de Souza; Jose Andres Morgado-Diaz
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-05       Impact factor: 4.553

3.  Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.

Authors:  Rajib Shome; Siddhartha Sankar Ghosh
Journal:  Cell Oncol (Dordr)       Date:  2021-01-04       Impact factor: 6.730

Review 4.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

5.  Effect of siRNA targeting MTA1 on metastasis malignant phenotype of ovarian cancer A2780 cells.

Authors:  Yu-Mei Rao; Mei Ji; Cai-Hong Chen; Hui-Rong Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

6.  PTEN Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERT Pathway in Lung Adenocarcinoma A549 Cells.

Authors:  Xiao-Xiao Lu; Lan-Yu Cao; Xi Chen; Jian Xiao; Yong Zou; Qiong Chen
Journal:  Biomed Res Int       Date:  2016-10-16       Impact factor: 3.411

7.  Increased expression of S100A6 promotes cell proliferation in gastric cancer cells.

Authors:  Xiao-Hong Wang; Hong Du; Lin Li; Duan-Fang Shao; Xi-Yao Zhong; Ying Hu; Yi-Qiang Liu; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Shen Li; Zi-Yu Li; Zhao-De Bu; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

8.  Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance.

Authors:  Mohan Singh; Parvesh Chaudhry; Francois Fabi; Eric Asselin
Journal:  BMC Cancer       Date:  2013-05-10       Impact factor: 4.430

9.  PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells.

Authors:  Suratchanee Phadngam; Andrea Castiglioni; Alessandra Ferraresi; Federica Morani; Carlo Follo; Ciro Isidoro
Journal:  Oncotarget       Date:  2016-12-20

10.  Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 Activity.

Authors:  Khadijeh Jamialahmadi; Sofia Salari; Nafiseh Sadat Alamolhodaei; Amir Avan; Leila Gholami; Gholamreza Karimi
Journal:  J Pharmacopuncture       Date:  2018-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.